270 related articles for article (PubMed ID: 11684669)
41. Active RB elicits late G1/S inhibition.
Angus SP; Fribourg AF; Markey MP; Williams SL; Horn HF; DeGregori J; Kowalik TF; Fukasawa K; Knudsen ES
Exp Cell Res; 2002 Jun; 276(2):201-13. PubMed ID: 12027450
[TBL] [Abstract][Full Text] [Related]
42. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
[TBL] [Abstract][Full Text] [Related]
43. Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth.
Ilyin GP; Glaise D; Gilot D; Baffet G; Guguen-Guillouzo C
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G115-27. PubMed ID: 12646420
[TBL] [Abstract][Full Text] [Related]
44. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS
Leukemia; 1997 Jan; 11(1):73-85. PubMed ID: 9001421
[TBL] [Abstract][Full Text] [Related]
45. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
46. A mechanistic basis for the coordinated regulation of pharyngeal morphogenesis in Caenorhabditis elegans by LIN-35/Rb and UBC-18-ARI-1.
Mani K; Fay DS
PLoS Genet; 2009 Jun; 5(6):e1000510. PubMed ID: 19521497
[TBL] [Abstract][Full Text] [Related]
47. NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1.
Yan GZ; Ziff EB
J Neurosci; 1995 Sep; 15(9):6200-12. PubMed ID: 7666202
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression.
Radeva G; Petrocelli T; Behrend E; Leung-Hagesteijn C; Filmus J; Slingerland J; Dedhar S
J Biol Chem; 1997 May; 272(21):13937-44. PubMed ID: 9153256
[TBL] [Abstract][Full Text] [Related]
49. Cyclin-dependent kinases regulate the antiproliferative function of Smads.
Matsuura I; Denissova NG; Wang G; He D; Long J; Liu F
Nature; 2004 Jul; 430(6996):226-31. PubMed ID: 15241418
[TBL] [Abstract][Full Text] [Related]
50. CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells.
Starostina NG; Simpliciano JM; McGuirk MA; Kipreos ET
Dev Cell; 2010 Nov; 19(5):753-64. PubMed ID: 21074724
[TBL] [Abstract][Full Text] [Related]
51. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1.
Nguyen MD; Boudreau M; Kriz J; Couillard-Després S; Kaplan DR; Julien JP
J Neurosci; 2003 Mar; 23(6):2131-40. PubMed ID: 12657672
[TBL] [Abstract][Full Text] [Related]
52. Phosphorylation of retinoblastoma-related protein by the cyclin D/cyclin-dependent kinase complex is activated at the G1/S-phase transition in tobacco.
Nakagami H; Kawamura K; Sugisaka K; Sekine M; Shinmyo A
Plant Cell; 2002 Aug; 14(8):1847-57. PubMed ID: 12172026
[TBL] [Abstract][Full Text] [Related]
53. A Cdk4/6-dependent phosphorylation gradient regulates the early to late G1 phase transition.
Kaulich M; Link VM; Lapek JD; Lee YJ; Glass CK; Gonzalez DJ; Dowdy SF
Sci Rep; 2021 Jul; 11(1):14736. PubMed ID: 34282211
[TBL] [Abstract][Full Text] [Related]
54. lin-35/Rb and xnp-1/ATR-X function redundantly to control somatic gonad development in C. elegans.
Bender AM; Wells O; Fay DS
Dev Biol; 2004 Sep; 273(2):335-49. PubMed ID: 15328017
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
56. The C. elegans hox gene lin-39 controls cell cycle progression during vulval development.
Roiz D; Escobar-Restrepo JM; Leu P; Hajnal A
Dev Biol; 2016 Oct; 418(1):124-134. PubMed ID: 27475488
[TBL] [Abstract][Full Text] [Related]
57. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
[TBL] [Abstract][Full Text] [Related]
58. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
Sarcevic B; Lilischkis R; Sutherland RL
J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
[TBL] [Abstract][Full Text] [Related]
59. Control of the G1/S transition.
Reed SI
Cancer Surv; 1997; 29():7-23. PubMed ID: 9338094
[TBL] [Abstract][Full Text] [Related]
60. New functional activities for the p21 family of CDK inhibitors.
LaBaer J; Garrett MD; Stevenson LF; Slingerland JM; Sandhu C; Chou HS; Fattaey A; Harlow E
Genes Dev; 1997 Apr; 11(7):847-62. PubMed ID: 9106657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
